Brussaard, H E <br/><br/>
Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM.  [electronic resource] 

 -  Diabetologia  Jul 1997 
 - 843-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0012-186X 
<br/><br/><label>Standard No.: </label>10.1007/s001250050758  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>C-Peptide--blood<br/>Cholesterol--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Estradiol--therapeutic use<br/>Estrogen Replacement Therapy<br/>Fatty Acids, Nonesterified--blood<br/>Female<br/>Fibrinolysis--drug effects<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Insulin Resistance<br/>Lipids--blood<br/>Lipoproteins--blood<br/>Middle Aged<br/>Plasminogen Activator Inhibitor 1--blood<br/>Postmenopause<br/>Tissue Plasminogen Activator--blood<br/>Triglycerides--blood